Get the full seragy company profile
Access contacts, investors, buying signals & more
Seragy has raised $13.4M to build out its biomarker platform for neurodegenerative diseases. The round drew backing from Commerzbank, Mittelständische Beteiligungsgesellschaft (MBG), and Land Niedersachsen.
The company's proprietary SeRAS platform amplifies tiny traces of misfolded proteins from patient samples into molecular fingerprints, a technique that reveals disease subtypes and yields quantitative translational biomarkers for targeted drug development.
seragy erhält 12 Mio. EUR für Biomarkerentwicklung seragy erhält 12 Mio. EUR für Biomarkerentwicklung - VC Magazin - seragy erhält 12 Mio. EUR für Biomarkerentwicklung Bildnachweis: Pexels , Sunriseforever – pixabay . Das Biotechnologieunternehmen seragy holding GmbH (ehem.
Prosperodes GmbH) hat sich eine Finanzierung in Höhe von 12 Mio. EUR gesichert. Mit dem Kapital will das Unternehmen seine SeRAS®-Technologie weiterentwickeln, die Labor- und Analysekapazitäten ausbauen und sein Team am Standort Hannover vergrößern. Langfristig soll die Technologie die Entwicklung gezielter Therapieansätze für neurodegenerative Erkrankungen unterstützen. seragy entwickelt quantita
amber Tech GmbH
amber is a European Business AI platform that connects to a company's existing systems to unify knowledge and provide AI-powered search, chat, and automation. It is designed to understand content in context while respecting existing user permissions, offering a secure and sovereign AI solution hosted in Germany and Europe.
$7.8M Unknown
today
Aerium
Aerium provides an AI workforce purpose-built for industrial manufacturers and distributors. The platform deploys always-on AI agents across supply chain, operations, commercial, and back office functions, leveraging custom-trained small language models and a unified operational data foundation to automate tasks, improve margins, and capture institutional knowledge.
$2.5M Seed
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | amber Tech GmbH | Unknown | $7.8M | today |
| 2 | Amaero Inc. | Unknown | $15.7M | today |
Complyance
Is it hard to remember and monitor all your certifications, permits, and licenses? Do you find compliance items slipping through the cracks and costing you fines? How many times have you missed a renewal? How often has the health department shown up and you did not have your updated certifications on hand? Are you using multiple applications to keep track of everything? We have your solution!
$1.5M Pre-series a
today
| $7.2B |
| 2y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |
 Housfy Spain |
| Unknown |
| $11.2M |
| today |
| 4 |  Retension Pharmaceuticals | Unknown | $45.0M | today |
| 5 | FollowTheVote | Unknown | $5.6K | today |
Commerzbank
INSTITUTIONAL
Mittelständische Beteiligungsgesellschaft (MBG)
Unlock 1 more investor and reach their contacts directly.
Start free trialchosen-by-dermatology
Recently received
Systole Health
Recently received
tollcyto-therapeutics
Recently received
